Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)
- Conditions
- Attention Deficit Disorder With Hyperactivity
- Registration Number
- NCT00018863
- Lead Sponsor
- New York State Psychiatric Institute
- Brief Summary
This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).
- Detailed Description
Young children age 3-5.5 years will be studied. The study includes treatment with different doses of methylphenidate and placebo; all children will receive active medication during the study. Prior to treatment, each child will receive a thorough psychiatric evaluation and each guardian will complete a 10-week workshop (2 hours/week). Throughout the study, parents and teachers will complete forms that report on the child's behavior and possible side effects. Participants will be monitored by regular visits with a study physician. Most participants will be involved in the study for up to 16 months to ensure optimal evaluation, dosing, and monitoring
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 165
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (6)
New York State Psychiatric Institute
🇺🇸New York, New York, United States
New York University School of Medicine
🇺🇸New York, New York, United States
University of California, Irvine
🇺🇸Irvine, California, United States
Johns Hopkins University
🇺🇸Baltimore, Maryland, United States
Duke University Medical Center
🇺🇸Durham, North Carolina, United States
University of California, Los Angeles
🇺🇸Los Angeles, California, United States